Australia markets closed

Fate Therapeutics, Inc. (FATE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.8000-0.0700 (-1.81%)
At close: 04:00PM EDT
3.8800 +0.08 (+2.11%)
After hours: 05:42PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
41,870
61,333
133,583
167,347
Other short-term investments
273,305
374,894
482,327
315,569
Total cash
315,175
436,227
615,910
482,916
Net receivables
1,826
38,480
8,676
5,515
Other current assets
14,539
27,367
8,826
-
Total current assets
331,540
502,074
633,412
494,323
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
206,137
206,473
179,194
110,487
Accumulated depreciation
-47,626
-30,384
-16,945
-11,095
Net property, plant and equipment
158,511
176,089
162,249
99,392
Equity and other investments
980
4,942
100,664
0
Other long-term assets
15,186
15,260
15,260
15,236
Total non-current assets
174,677
203,487
288,043
128,134
Total assets
506,217
705,561
921,455
622,457
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
4,719
8,265
8,612
6,283
Accrued liabilities
27,514
53,932
42,412
15,564
Deferred revenues
685
42,226
21,483
21,144
Other current liabilities
-
4,000
3,200
39,218
Total current liabilities
39,094
114,051
81,284
85,564
Non-current liabilities
Deferred revenues
-
0
27,124
46,021
Other long-term liabilities
-
-
800
800
Total non-current liabilities
98,706
107,571
161,333
152,448
Total liabilities
137,800
221,622
242,617
238,012
Stockholders' equity
Common stock
102
100
99
91
Retained earnings
-1,211,732
-1,050,804
-769,083
-556,932
Accumulated other comprehensive income
15
-1,854
-762
70
Total stockholders' equity
368,417
483,939
678,838
384,445
Total liabilities and stockholders' equity
506,217
705,561
921,455
622,457